Log in to save to my catalogue

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11350217

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm

About this item

Full title

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical cardiology (Mahwah, N.J.), 2024-09, Vol.47 (9), p.e70004-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

ABSTRACT
Background
Vasoreactivity testing, such as intracoronary acetylcholine (ACh) or ergometrine (EM), is defined as Class I for the diagnosis of patients with vasospastic angina (VSA) according to recommendations from the Coronary Vasomotion Disorders International Study (COVADIS) group and guidelines from the Japanese Circulation Societ...

Alternative Titles

Full title

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11350217

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11350217

Other Identifiers

ISSN

0160-9289,1932-8737

E-ISSN

1932-8737

DOI

10.1002/clc.70004

How to access this item